XML 33 R22.htm IDEA: XBRL DOCUMENT v3.26.1
Stock Plans and Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option
A summary of stock option activity under the 2026 Plan, 2010 Plan, and Inducement Awards are summarized as follows:
Number of
Shares
Weighted
Average
Exercise
Price per
Share
Weighted
Average
Remaining Contractual Life
Aggregate Intrinsic Value
Outstanding, December 31, 20252,429,064 $16.59 7.80$— 
Granted— — 
Exercised— — 
Canceled/Forfeited(101,599)37.64 
Outstanding, March 31, 2026
2,327,465 $15.67 7.40$— 
Exercisable at March 31, 2026
1,164,823 $28.71 6.02$— 
Vested and unvested expected to vest at March 31, 2026
2,327,465 $15.67 7.40$— 
Schedule of Valuation Assumptions Used to Calculate Fair Value of Employee Options Awarded
The weighted average grant date fair value of the stock options granted during the three months ended March 31, 2025 was $2.67 and was calculated using the following estimated assumptions under the Black-Scholes option pricing model:
Three Months Ended March 31,
 2025
Expected term (years) 6.0
Risk free interest rate
4.4%
Expected volatility
113%
Expected dividendsNone
Schedule of Restricted Stock Awards
The following table presents a summary of RSUs under the 2010 Plan as of March 31, 2026:
Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 2025257,400 $3.13 
Awarded— — 
Vested(64,350)3.13 
Forfeited(44,700)3.13 
Unvested, March 31, 2026
148,350 $3.13 
Schedule of Stock-Based Compensation Expense
For the three months ended March 31, 2026 and 2025, the Company recorded stock-based compensation expense to the following line items in its costs and expenses section of the Condensed Consolidated Statements of Operations and Comprehensive Loss:
 Three Months Ended March 31,
(in thousands)20262025
Research and development$229 $592 
General and administrative346 572 
Total stock-based compensation expense$575 $1,164